{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:47:16Z","timestamp":1792784836772,"version":"4.5.0"},"reference-count":265,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T00:00:00Z","timestamp":1588204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005302","name":"Alexander S. Onassis Public Benefit Foundation","doi-asserted-by":"publisher","award":["GZL044-1\/2015-2016"],"award-info":[{"award-number":["GZL044-1\/2015-2016"]}],"id":[{"id":"10.13039\/501100005302","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Georgia and Athanassios Martinos Family"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The potential existence and roles of the meningeal lymphatic system in normal and pathological brain function have been a long-standing enigma. Recent evidence suggests that meningeal lymphatic vessels are present in both the mouse and human brain; in mice, they seem to play a role in clearing toxic amyloid-beta peptides, which have been connected with Alzheimer disease (AD). Here, we review the evidence linking the meningeal lymphatic system with human AD. Novel findings suggest that the recently described meningeal lymphatic vessels could be linked to, and possibly drain, the efferent paravascular glial lymphatic (glymphatic) system carrying cerebrospinal fluid, after solute and immune cell exchange with brain interstitial fluid. In so doing, the glymphatic system could contribute to the export of toxic solutes and immune cells from the brain (an exported fluid we wish to describe as glymph, similarly to lymph) to the meningeal lymphatic system; the latter, by being connected with downstream anatomic regions, carries the glymph to the conventional cervical lymphatic vessels and nodes. Thus, abnormal function in the meningeal lymphatic system could, in theory, lead to the accumulation, in the brain, of amyloid-beta, cellular debris, and inflammatory mediators, as well as immune cells, resulting in damage of the brain parenchyma and, in turn, cognitive and other neurologic dysfunctions. In addition, we provide novel insights into APOE4\u2014the leading genetic risk factor for AD\u2014and its relation to the meningeal lymphatic system. In this regard, we have reanalyzed previously published RNA-Seq data to show that induced pluripotent stem cells (iPSCs) carrying the\n                    <jats:italic>APOE4<\/jats:italic>\n                    allele (either as\n                    <jats:italic>APOE4<\/jats:italic>\n                    knock-in or stemming from\n                    <jats:italic>APOE4<\/jats:italic>\n                    patients) express lower levels of (a) genes associated with lymphatic markers, and (b) genes for which well-characterized missense mutations have been linked to peripheral lymphedema. Taking into account this evidence, we propose a new conceptual framework, according to which APOE4 could play a novel role in the premature shrinkage of meningeal lymphatic vessels (meningeal lymphosclerosis), leading to abnormal meningeal lymphatic functions (meningeal lymphedema), and, in turn, reduction in the clearance of amyloid-beta and other macromolecules and inflammatory mediators, as well as immune cells, from the brain, exacerbation of AD manifestations, and progression of the disease. Altogether, these findings and their potential interpretations may herald novel diagnostic tools and therapeutic approaches in patients with AD.\n                  <\/jats:p>","DOI":"10.1038\/s41380-020-0731-7","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T06:03:55Z","timestamp":1588226635000},"page":"1075-1097","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Apolipoprotein E4 and meningeal lymphatics in Alzheimer disease: a conceptual framework"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1480-390X","authenticated-orcid":false,"given":"Alexios-Fotios A.","family":"Mentis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthimios","family":"Dardiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George P.","family":"Chrousos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,30]]},"reference":[{"key":"731_CR1","unstructured":"World Health Organization. WHO guidelines approved by the Guidelines Review Committee. Risk reduction of cognitive decline and dementia: WHO Guidelines. Geneva: World Health Organization; 2019."},{"key":"731_CR2","doi-asserted-by":"crossref","first-page":"15056.","DOI":"10.1038\/nrdp.2015.56","volume":"1","author":"CL Masters","year":"2015","unstructured":"Masters CL, Bateman R, Blennow K, Rowe CC, Sperling RA, Cummings JL. Alzheimer\u2019s disease. Nat Rev Dis Prim. 2015;1:15056.","journal-title":"Nat Rev Dis Prim"},{"key":"731_CR3","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/jamaneurol.2019.1971","volume":"76","author":"CR Jack","year":"2019","unstructured":"Jack CR, Therneau TM, Weigand SD, Wiste HJ, Knopman DS, Vemuri P, et al. Prevalence of biologically vs clinically defined Alzheimer spectrum entities using the National Institute on Aging\u2013Alzheimer\u2019s Association research framework. JAMA Neurol. 2019;76:1174\u201383.","journal-title":"JAMA Neurol"},{"key":"731_CR4","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1056\/NEJMp1716381","volume":"378","author":"G Devi","year":"2018","unstructured":"Devi G. Alzheimer\u2019s disease in physicians\u2014assessing professional competence and tempering stigma. N Engl J Med. 2018;378:1073\u20135.","journal-title":"N Engl J Med"},{"key":"731_CR5","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/jnnp-2014-309582","volume":"87","author":"NM Scheltens","year":"2016","unstructured":"Scheltens NM, Galindo-Garre F, Pijnenburg YA, van der Vlies AE, Smits LL, Koene T, et al. The identification of cognitive subtypes in Alzheimer\u2019s disease dementia using latent class analysis. J Neurol Neurosurg Psychiatry. 2016;87:235\u201343.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"731_CR6","doi-asserted-by":"crossref","unstructured":"Thomas KR, Bangen KJ, Weigand AJ, Edmonds EC, Wong CG, Cooper S, et al. Objective subtle cognitive difficulties predict future amyloid accumulation and neurodegeneration. Neurology. 2020 Jan 28;94:e397\u2013e406.","DOI":"10.1212\/WNL.0000000000008838"},{"key":"731_CR7","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jalz.2016.07.152","volume":"13","author":"V Bellou","year":"2017","unstructured":"Bellou V, Belbasis L, Tzoulaki I, Middleton LT, Ioannidis JPA, Evangelou E. Systematic evaluation of the associations between environmental risk factors and dementia: an umbrella review of systematic reviews and meta-analyses. Alzheimer\u2019s Dement. 2017;13:406\u201318.","journal-title":"Alzheimer\u2019s Dement"},{"key":"731_CR8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.neubiorev.2016.06.003","volume":"74","author":"NC Gassen","year":"2017","unstructured":"Gassen NC, Chrousos GP, Binder EB, Zannas AS. Life stress, glucocorticoid signaling, and the aging epigenome: implications for aging-related diseases. Neurosci Biobehav Rev. 2017;74:356\u201365.","journal-title":"Neurosci Biobehav Rev"},{"key":"731_CR9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000362736","volume":"22","author":"NC Nicolaides","year":"2015","unstructured":"Nicolaides NC, Kyratzi E, Lamprokostopoulou A, Chrousos GP, Charmandari E. Stress, the stress system and the role of glucocorticoids. Neuroimmunomodulation. 2015;22:6\u201319.","journal-title":"Neuroimmunomodulation"},{"key":"731_CR10","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fnagi.2019.00269","volume":"11","author":"G Canet","year":"2019","unstructured":"Canet G, Hernandez C, Zussy C, Chevallier N, Desrumaux C, Givalois L. Is AD a stress-related disorder? Focus on the HPA axis and its promising therapeutic targets. Front Aging Neurosci. 2019;11:269.","journal-title":"Front Aging Neurosci"},{"key":"731_CR11","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/mp.2016.185","volume":"22","author":"D Bangasser","year":"2017","unstructured":"Bangasser D, Dong H, Carroll J, Plona Z, Ding H, Rodriguez L, et al. Corticotropin-releasing factor overexpression gives rise to sex differences in Alzheimer\u2019s disease-related signaling. Mol Psychiatry. 2017;22:1126.","journal-title":"Mol Psychiatry"},{"key":"731_CR12","doi-asserted-by":"crossref","first-page":"610813","DOI":"10.1155\/2015\/610813","volume":"2015","author":"R Fischer","year":"2015","unstructured":"Fischer R, Maier O. Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF. Oxid Med Cell Longev. 2015;2015:610813.","journal-title":"Oxid Med Cell Longev"},{"key":"731_CR13","doi-asserted-by":"crossref","unstructured":"Lecca D, Bader M, Tweedie D, Hoffman AF, Jung YJ, Hsueh SC, et al. (-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer\u2019s disease challenged mice. Neurobio Dis. 2019;130:104528.","DOI":"10.1016\/j.nbd.2019.104528"},{"key":"731_CR14","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","volume":"353","author":"RM Ransohoff","year":"2016","unstructured":"Ransohoff RM. How neuroinflammation contributes to neurodegeneration. Science. 2016;353:777\u201383.","journal-title":"Science"},{"key":"731_CR15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41586-018-0368-8","volume":"560","author":"S Da Mesquita","year":"2018","unstructured":"Da Mesquita S, Louveau A, Vaccari A, Smirnov I, Cornelison RC, Kingsmore KM, et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer\u2019s disease. Nature. 2018;560:185\u201391.","journal-title":"Nature"},{"key":"731_CR16","first-page":"848","volume":"79","author":"D Michelson","year":"1994","unstructured":"Michelson D, Stone L, Galliven E, Magiakou MA, Chrousos GP, Sternberg EM, et al. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J Clin Endocrinol Metab. 1994;79:848\u201353.","journal-title":"J Clin Endocrinol Metab"},{"key":"731_CR17","doi-asserted-by":"crossref","unstructured":"Pervanidou P, Chrousos GP. Neuroendocrinology of post-traumatic stress disorder. In: Progress in brain research, Vol. 182. Elsevier; Amsterdam, Netherlands; 2010. p. 149\u201360.","DOI":"10.1016\/S0079-6123(10)82005-9"},{"key":"731_CR18","volume":"7","author":"CP Le","year":"2016","unstructured":"Le CP, Nowell CJ, Kim-Fuchs C, Botteri E, Hiller JG, Ismail H, et al. Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination. Nat Commun. 2016;7:10634.","journal-title":"Nat Commun"},{"key":"731_CR19","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1056\/NEJM199505183322008","volume":"332","author":"GP Chrousos","year":"1995","unstructured":"Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995;332:1351\u201362.","journal-title":"N Engl J Med"},{"key":"731_CR20","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nrendo.2009.106","volume":"5","author":"GP Chrousos","year":"2009","unstructured":"Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009;5:374.","journal-title":"Nat Rev Endocrinol"},{"key":"731_CR21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature14252","volume":"518","author":"E Gjoneska","year":"2015","unstructured":"Gjoneska E, Pfenning AR, Mathys H, Quon G, Kundaje A, Tsai LH, et al. Conserved epigenomic signals in mice and humans reveal immune basis of Alzheimer\u2019s disease. Nature. 2015;518:365\u20139.","journal-title":"Nature"},{"key":"731_CR22","doi-asserted-by":"crossref","unstructured":"Heckmann BL, Teubner BJW, Tummers B, Boada-Romero E, Harris L, Yang M, et al. LC3-associated endocytosis facilitates beta-amyloid clearance and mitigates neurodegeneration in murine Alzheimer\u2019s disease. Cell. 2019;178:536\u201351.e14.","DOI":"10.1016\/j.cell.2019.05.056"},{"key":"731_CR23","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, et al. NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature. 2013;493:674\u20138.","journal-title":"Nature"},{"key":"731_CR24","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016;352:712\u20136.","journal-title":"Science"},{"key":"731_CR25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"C-C Liu","year":"2013","unstructured":"Liu C-C, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9:106\u2013118.","journal-title":"Nat Rev Neurol"},{"key":"731_CR26","doi-asserted-by":"crossref","unstructured":"Nortley R, Korte N, Izquierdo P, Hirunpattarasilp C, Mishra A, Jaunmuktane Z, et al. Amyloid beta oligomers constrict human capillaries in Alzheimer\u2019s disease via signaling to pericytes. Science. 2019;365:eaav9518.","DOI":"10.1126\/science.aav9518"},{"key":"731_CR27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1373\/clinchem.2016.255695","volume":"63","author":"RW Mahley","year":"2017","unstructured":"Mahley RW. Apolipoprotein E: remarkable protein sheds light on cardiovascular and neurological diseases. Clin Chem. 2017;63:14\u201320.","journal-title":"Clin Chem"},{"key":"731_CR28","doi-asserted-by":"crossref","unstructured":"Hudry E, Klickstein J, Cannavo C, Jackson R, Muzikansky A, Gandhi S, et al. Opposing roles of apolipoprotein E in aging and neurodegeneration. Life Sci Alliance. 2019;2:e201900325.","DOI":"10.26508\/lsa.201900325"},{"key":"731_CR29","doi-asserted-by":"crossref","unstructured":"Arboleda-Velasquez JF, Lopera F, O\u2019Hare M, Delgado-Tirado S, Marino C, Chmielewska N, et al. Resistance to autosomal dominant Alzheimer\u2019s disease in an APOE3 Christchurch homozygote: a case report. Nat Med. 2019;25:1680\u201383.","DOI":"10.1038\/s41591-019-0611-3"},{"key":"731_CR30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neubiorev.2018.08.009","volume":"94","author":"GH Weissberger","year":"2018","unstructured":"Weissberger GH, Nation DA, Nguyen CP, Bondi MW, Han SD. Meta-analysis of cognitive ability differences by apolipoprotein e genotype in young humans. Neurosci Biobehav Rev. 2018;94:49\u201358.","journal-title":"Neurosci Biobehav Rev"},{"key":"731_CR31","doi-asserted-by":"publisher","unstructured":"Ritchie SJ, Hill WD, Marioni RE, Davies G, Hagenaars SP, Harris SE, et al. Polygenic predictors of age-related decline in cognitive ability. Mol Psychiatry. 2019. https:\/\/doi.org\/10.1038\/s41380-019-0372-x. [Online ahead of print].","DOI":"10.1038\/s41380-019-0372-x"},{"key":"731_CR32","doi-asserted-by":"crossref","unstructured":"Glorioso CA, Pfenning AR, Lee SS, Bennett DA, Sibille EL, Kellis M, et al. Rate of brain aging and APOE epsilon4 are synergistic risk factors for Alzheimer\u2019s disease. Life Sci Alliance. 2019;2:e201900303.","DOI":"10.26508\/lsa.201900303"},{"key":"731_CR33","doi-asserted-by":"crossref","unstructured":"Xian X, Pohlkamp T, Durakoglugil MS, Wong CH, Beck JK, Lane-Donovan C, et al. Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer\u2019s disease. eLife. 2018;7:e40048.","DOI":"10.7554\/eLife.40048"},{"key":"731_CR34","doi-asserted-by":"crossref","first-page":"c3885","DOI":"10.1136\/bmj.c3885","volume":"341","author":"K Ritchie","year":"2010","unstructured":"Ritchie K, Carri\u00e8re I, Ritchie C, Berr C, Artero S, Ancelin M-L. Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ. 2010;341:c3885.","journal-title":"BMJ"},{"key":"731_CR35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000490739","volume":"77","author":"V De Luca","year":"2019","unstructured":"De Luca V, Spalletta G, Souza RP, Graff A, Bastos-Rodrigues L, Camargos Bicalho MA. Definition of late onset Alzheimer\u2019s disease and anticipation effect of genome-wide significant risk variants: pilot study of the APOE e4 allele. Neuropsychobiology. 2019;77:8\u201312.","journal-title":"Neuropsychobiology"},{"key":"731_CR36","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1172\/JCI96429","volume":"128","author":"F Liao","year":"2018","unstructured":"Liao F, Li A, Xiong M, Bien-Ly N, Jiang H, Zhang Y, et al. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J Clin Investig. 2018;128:2144\u201355.","journal-title":"J Clin Investig"},{"key":"731_CR37","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jalz.2018.02.005","volume":"14","author":"J Tulloch","year":"2018","unstructured":"Tulloch J, Leong L, Chen S, Keene CD, Millard SP, Shutes-David A, et al. APOE DNA methylation is altered in Lewy body dementia. Alzheimer\u2019s Dement. 2018;14:889\u201394.","journal-title":"Alzheimer\u2019s Dement"},{"key":"731_CR38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.nbd.2016.06.004","volume":"94","author":"JT Geiger","year":"2016","unstructured":"Geiger JT, Ding J, Crain B, Pletnikova O, Letson C, Dawson TM, et al. Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies. Neurobiol Dis. 2016;94:55\u201362.","journal-title":"Neurobiol Dis"},{"key":"731_CR39","doi-asserted-by":"crossref","first-page":"e1182","DOI":"10.1212\/WNL.0000000000006212","volume":"91","author":"DW Dickson","year":"2018","unstructured":"Dickson DW, Heckman MG, Murray ME, Soto AI, Walton RL, Diehl NN, et al. APOE epsilon4 is associated with severity of Lewy body pathology independent of Alzheimer pathology. Neurology. 2018;91:e1182\u2013e1195.","journal-title":"Neurology"},{"key":"731_CR40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamaneurol.2013.600","volume":"70","author":"D Tsuang","year":"2013","unstructured":"Tsuang D, Leverenz JB, Lopez OL, Hamilton RL, Bennett DA, Schneider JA, et al. APOE epsilon4 increases risk for dementia in pure synucleinopathies. JAMA Neurol. 2013;70:223\u20138.","journal-title":"JAMA Neurol"},{"key":"731_CR41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jalz.2018.08.002","volume":"15","author":"YF Lin","year":"2019","unstructured":"Lin YF, Smith AV, Aspelund T, Betensky RA, Smoller JW, Gudnason V, et al. Genetic overlap between vascular pathologies and Alzheimer\u2019s dementia and potential causal mechanisms. Alzheimer\u2019s Dement. 2019;15:65\u201375.","journal-title":"Alzheimer\u2019s Dement"},{"key":"731_CR42","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jalz.2018.02.003","volume":"14","author":"T Skillback","year":"2018","unstructured":"Skillback T, Lautner R, Mattsson N, Schott JM, Skoog I, Nagga K, et al. Apolipoprotein E genotypes and longevity across dementia disorders. Alzheimer\u2019s Dement. 2018;14:895\u2013901.","journal-title":"Alzheimer\u2019s Dement"},{"key":"731_CR43","doi-asserted-by":"crossref","first-page":"134ed134","DOI":"10.1126\/scitranslmed.3004274","volume":"4","author":"S Gandy","year":"2012","unstructured":"Gandy S, Dekosky ST. APOE epsilon4 status and traumatic brain injury on the gridiron or the battlefield. Sci Transl Med. 2012;4:134ed134.","journal-title":"Sci Transl Med"},{"key":"731_CR44","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-019-1299-4","volume":"17","author":"M Safieh","year":"2019","unstructured":"Safieh M, Korczyn AD, Michaelson DM. ApoE4: an emerging therapeutic target for Alzheimer\u2019s disease. BMC Med. 2019;17:64.","journal-title":"BMC Med"},{"key":"731_CR45","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jalz.2018.08.007","volume":"15","author":"M Lamar","year":"2019","unstructured":"Lamar M, Yu L, Rubin LH, James BD, Barnes LL, Farfel JM, et al. APOE genotypes as a risk factor for age-dependent accumulation of cerebrovascular disease in older adults. Alzheimer\u2019s Dement. 2019; 15:258\u201366.","journal-title":"Alzheimer\u2019s Dement"},{"key":"731_CR46","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jamaneurol.2018.3139","volume":"75","author":"AM Wennberg","year":"2018","unstructured":"Wennberg AM, Tosakulwong N, Lesnick TG, Murray ME, Whitwell JL, Liesinger AM, et al. Association of apolipoprotein E epsilon4 with transactive response DNA-binding protein 43. JAMA Neurol. 2018;75:1347\u201354.","journal-title":"JAMA Neurol"},{"key":"731_CR47","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/mp.2015.177","volume":"21","author":"JI Velez","year":"2016","unstructured":"Velez JI, Lopera F, Sepulveda-Falla D, Patel HR, Johar AS, Chuah A, et al. APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer\u2019s disease. Mol Psychiatry. 2016;21:916\u201324.","journal-title":"Mol Psychiatry"},{"key":"731_CR48","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2174\/15672050113109990156","volume":"10","author":"PS Hauser","year":"2013","unstructured":"Hauser PS, Ryan RO. Impact of apolipoprotein E on Alzheimer\u2019s disease. Curr Alzheimer Res. 2013;10:809\u201317.","journal-title":"Curr Alzheimer Res"},{"key":"731_CR49","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/WAD.0000000000000195","volume":"31","author":"DJ Moreno","year":"2017","unstructured":"Moreno DJ, Pino S, Rios A, Lopera F, Ostos H, Via M, et al. Genetic Ancestry And Susceptibility To Late-onset Alzheimer disease (LOAD) in the admixed Colombian population. Alzheimer Dis Assoc Disord. 2017;31:225\u201331.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"731_CR50","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1001\/jama.2013.2973","volume":"309","author":"C Reitz","year":"2013","unstructured":"Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BN, Wang LS, et al. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E 4,and the risk of late-onset Alzheimer disease in African Americans. JAMA. 2013;309:1483\u201392.","journal-title":"JAMA"},{"key":"731_CR51","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/ana.410370217","volume":"37","author":"G Maestre","year":"1995","unstructured":"Maestre G, Ottman R, Stern Y, Gurland B, Chun M, Tang MX, et al. Apolipoprotein E and Alzheimer\u2019s disease: ethnic variation in genotypic risks. Ann Neurol. 1995;37:254\u20139.","journal-title":"Ann Neurol"},{"key":"731_CR52","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jalz.2018.02.009","volume":"14","author":"N Mattsson","year":"2018","unstructured":"Mattsson N, Groot C, Jansen WJ, Landau SM, Villemagne VL, Engelborghs S, et al. Prevalence of the apolipoprotein E epsilon4 allele in amyloid beta positive subjects across the spectrum of Alzheimer\u2019s disease. Alzheimer\u2019s Demen. 2018;14:913\u201324.","journal-title":"Alzheimer\u2019s Demen"},{"key":"731_CR53","doi-asserted-by":"crossref","first-page":"101800","DOI":"10.1016\/j.nicl.2019.101800","volume":"22","author":"R Duara","year":"2019","unstructured":"Duara R, Loewenstein DA, Lizarraga G, Adjouadi M, Barker WW, Greig-Custo MT, et al. Effect of age, ethnicity, sex, cognitive status and APOE genotype on amyloid load and the threshold for amyloid positivity. NeuroImage Clin. 2019;22:101800.","journal-title":"NeuroImage Clin"},{"key":"731_CR54","doi-asserted-by":"crossref","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15:501\u201318.","DOI":"10.1038\/s41582-019-0228-7"},{"key":"731_CR55","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1172\/JCI124853","volume":"129","author":"M Tachibana","year":"2019","unstructured":"Tachibana M, Holm ML, Liu CC, Shinohara M, Aikawa T, Oue H, et al. APOE4-mediated amyloid-beta pathology depends on its neuronal receptor LRP1. J Clin Investig. 2019;129:1272\u20137.","journal-title":"J Clin Investig"},{"key":"731_CR56","doi-asserted-by":"publisher","unstructured":"Yan Q, Nho K, Del-Aguila JL, Wang X, Risacher SL, Fan KH, et al. Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging. Mol Psychiatry. 2018. https:\/\/doi.org\/10.1038\/s41380-018-0246-7. [Online ahead of print].","DOI":"10.1038\/s41380-018-0246-7"},{"key":"731_CR57","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/mp.2014.123","volume":"20","author":"YY Lim","year":"2015","unstructured":"Lim YY, Villemagne VL, Laws SM, Pietrzak RH, Snyder PJ, Ames D, et al. APOE and BDNF polymorphisms moderate amyloid beta-related cognitive decline in preclinical Alzheimer\u2019s disease. Mol Psychiatry. 2015;20:1322\u20138.","journal-title":"Mol Psychiatry"},{"key":"731_CR58","doi-asserted-by":"crossref","first-page":"13247","DOI":"10.1074\/jbc.RA117.001388","volume":"293","author":"E Kara","year":"2018","unstructured":"Kara E, Marks JD, Roe AD, Commins C, Fan Z, Calvo-Rodriguez M, et al. A flow cytometry-based in vitro assay reveals that formation of apolipoprotein E (ApoE)-amyloid beta complexes depends on ApoE isoform and cell type. J Biol Chem. 2018;293:13247\u201356.","journal-title":"J Biol Chem"},{"key":"731_CR59","doi-asserted-by":"crossref","first-page":"15163","DOI":"10.1074\/jbc.M114.622209","volume":"290","author":"Y Hori","year":"2015","unstructured":"Hori Y, Hashimoto T, Nomoto H, Hyman BT, Iwatsubo T. Role of apolipoprotein E in beta-amyloidogenesis: isoform-specific effects on protofibril to fibril conversion of abeta in vitro and brain abeta deposition in vivo. J Biol Chem. 2015;290:15163\u201374.","journal-title":"J Biol Chem"},{"key":"731_CR60","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.neuron.2016.08.027","volume":"91","author":"A Louveau","year":"2016","unstructured":"Louveau A, Da Mesquita S, Kipnis J. Lymphatics in neurological disorders: a neuro-lympho-vascular component of multiple sclerosis and Alzheimer\u2019s disease? Neuron. 2016;91:957\u201373.","journal-title":"Neuron"},{"key":"731_CR61","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","volume":"96","author":"CC Liu","year":"2017","unstructured":"Liu CC, Zhao N, Fu Y, Wang N, Linares C, Tsai CW, et al. ApoE4 accelerates early seeding of amyloid pathology. Neuron. 2017;96:1024\u20131032.e1023.","journal-title":"Neuron"},{"key":"731_CR62","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.neubiorev.2016.09.012","volume":"71","author":"AF Mentis","year":"2016","unstructured":"Mentis AF. Epigenomic engineering for Down syndrome. Neurosci Biobehav Rev. 2016;71:323\u20137.","journal-title":"Neurosci Biobehav Rev"},{"key":"731_CR63","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1093\/brain\/awy159","volume":"141","author":"FK Wiseman","year":"2018","unstructured":"Wiseman FK, Pulford LJ, Barkus C, Liao F, Portelius E, Webb R, et al. Trisomy of human chromosome 21 enhances amyloid-\u03b2 deposition independently of an extra copy of APP. Brain. 2018;141:2457\u201374.","journal-title":"Brain"},{"key":"731_CR64","doi-asserted-by":"crossref","unstructured":"Hithersay R, Startin CM, Hamburg S, Mok KY, Hardy J, Fisher EMC, et al. Association of dementia with mortality among adults with Down syndrome older than 35 years. JAMA Neurol. 2019;76:152\u201360.","DOI":"10.1001\/jamaneurol.2018.3616"},{"key":"731_CR65","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pneurobio.2018.12.005","volume":"175","author":"C Tapia-Rojas","year":"2019","unstructured":"Tapia-Rojas C, Cabezas-Opazo F, Deaton CA, Vergara EH, Johnson GVW, Quintanilla RA. It\u2019s all about tau. Prog Neurobiol. 2019;175:54\u201376.","journal-title":"Prog Neurobiol"},{"key":"731_CR66","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature24016","volume":"549","author":"Y Shi","year":"2017","unstructured":"Shi Y, Yamada K, Liddelow SA, Smith ST, Zhao L, Luo W, et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 2017;549:523\u20137.","journal-title":"Nature"},{"key":"731_CR67","doi-asserted-by":"crossref","unstructured":"Wadhwani AR, Affaneh A, Van Gulden S, Kessler JA. Neuronal apolipoprotein E4 increases cell death and p-tau release in Alzheimer\u2019s disease. Ann Neurol. 2019;85:726\u201339.","DOI":"10.1002\/ana.25455"},{"key":"731_CR68","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/brain\/awy289","volume":"142","author":"KY Peng","year":"2019","unstructured":"Peng KY, Perez-Gonzalez R, Alldred MJ, Goulbourne CN, Morales-Corraliza J, Saito M, et al. Apolipoprotein E4 genotype compromises brain exosome production. Brain. 2019;142:163\u201375.","journal-title":"Brain"},{"key":"731_CR69","doi-asserted-by":"crossref","first-page":"ra29","DOI":"10.1126\/scisignal.aad5578","volume":"9","author":"Y Ding","year":"2016","unstructured":"Ding Y, Huang L, Xian X, Yuhanna IS, Wasser CR, Frotscher M, et al. Loss of reelin protects against atherosclerosis by reducing leukocyte-endothelial cell adhesion and lesion macrophage accumulation. Sci Signal. 2016;9:ra29.","journal-title":"Sci Signal"},{"key":"731_CR70","doi-asserted-by":"crossref","first-page":"ra67","DOI":"10.1126\/scisignal.aaa6674","volume":"8","author":"C Lane-Donovan","year":"2015","unstructured":"Lane-Donovan C, Philips GT, Wasser CR, Durakoglugil MS, Masiulis I, Upadhaya A, et al. Reelin protects against amyloid beta toxicity in vivo. Sci Signal. 2015;8:ra67.","journal-title":"Sci Signal"},{"key":"731_CR71","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1037\/tps0000124","volume":"3","author":"SE Setti","year":"2017","unstructured":"Setti SE, Hunsberger HC, Reed MN. Alterations in hippocampal activity and Alzheimer\u2019s disease. Transl Issues Psychol Sci. 2017;3:348.","journal-title":"Transl Issues Psychol Sci"},{"key":"731_CR72","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.neuron.2014.10.024","volume":"84","author":"Z \u0160i\u0161kov\u00e1","year":"2014","unstructured":"\u0160i\u0161kov\u00e1 Z, Justus D, Kaneko H, Friedrichs D, Henneberg N, Beutel T, et al. Dendritic structural degeneration is functionally linked to cellular hyperexcitability in a mouse model of Alzheimer\u2019s disease. Neuron. 2014;84:1023\u201333.","journal-title":"Neuron"},{"key":"731_CR73","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-019-0324-6","volume":"14","author":"R Najm","year":"2019","unstructured":"Najm R, Jones EA, Huang Y. Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer\u2019s disease. Mol Neurodegener. 2019;14:24.","journal-title":"Mol Neurodegener"},{"key":"731_CR74","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.neurobiolaging.2007.11.014","volume":"30","author":"MP Vitek","year":"2009","unstructured":"Vitek MP, Brown CM, Colton CA. APOE genotype-specific differences in the innate immune response. Neurobiol Aging. 2009;30:1350\u201360.","journal-title":"Neurobiol Aging"},{"key":"731_CR75","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ni.3102","volume":"16","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Golenbock DT, Latz E. Innate immunity in Alzheimer\u2019s disease. Nat Immunol. 2015;16:229\u201336.","journal-title":"Nat Immunol"},{"key":"731_CR76","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"C Sala Frigerio","year":"2019","unstructured":"Sala Frigerio C, Wolfs L, Fattorelli N, Thrupp N, Voytyuk I, Schmidt I, et al. The major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to abeta plaques. Cell Rep. 2019;27:1293\u2013.e1296.","journal-title":"Cell Rep."},{"key":"731_CR77","doi-asserted-by":"crossref","first-page":"194.e113","DOI":"10.1016\/j.neurobiolaging.2017.01.015","volume":"53","author":"E Dardiotis","year":"2017","unstructured":"Dardiotis E, Siokas V, Pantazi E, Dardioti M, Rikos D, Xiromerisiou G, et al. A novel mutation in TREM2 gene causing Nasu-Hakola disease and review of the literature. Neurobiol Aging. 2017;53:194.e113\u201322.","journal-title":"Neurobiol Aging"},{"key":"731_CR78","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47:566\u2013581.e569.","journal-title":"Immunity"},{"key":"731_CR79","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuron.2016.06.015","volume":"91","author":"FL Yeh","year":"2016","unstructured":"Yeh FL, Wang Y, Tom I, Gonzalez LC, Sheng M. TREM2 binds to apolipoproteins, including APOE and CLU\/APOJ, and thereby facilitates uptake of amyloid-beta by microglia. Neuron. 2016;91:328\u201340.","journal-title":"Neuron"},{"key":"731_CR80","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41593-018-0296-9","volume":"22","author":"S Parhizkar","year":"2019","unstructured":"Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci. 2019;22:191\u2013204.","journal-title":"Nat Neurosci"},{"key":"731_CR81","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims R, Van Der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat Genet. 2017;49:1373.","journal-title":"Nat Genet"},{"key":"731_CR82","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJMe1213157","volume":"368","author":"H Neumann","year":"2013","unstructured":"Neumann H, Daly MJ. Variant TREM2 as risk factor for Alzheimer\u2019s disease. N Engl J Med. 2013;368:182\u20134.","journal-title":"N Engl J Med"},{"key":"731_CR83","first-page":"1567","volume":"369","author":"BA Benitez","year":"2013","unstructured":"Benitez BA, Cruchaga C. TREM2 and neurodegenerative disease. N Engl J Med. 2013;369:1567\u20138.","journal-title":"N Engl J Med"},{"key":"731_CR84","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368:117\u201327.","journal-title":"N Engl J Med"},{"key":"731_CR85","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jalz.2014.05.1751","volume":"10","author":"CF Slattery","year":"2014","unstructured":"Slattery CF, Beck JA, Harper L, Adamson G, Abdi Z, Uphill J, et al. R47H TREM2 variant increases risk of typical early-onset Alzheimer\u2019s disease but not of prion or frontotemporal dementia. Alzheimer\u2019s Dement. 2014;10:602\u2013608.e604.","journal-title":"Alzheimer\u2019s Dement"},{"key":"731_CR86","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368:107\u201316.","journal-title":"N Engl J Med"},{"key":"731_CR87","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jalz.2018.07.222","volume":"15","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, et al. Vascular dysfunction-The disregarded partner of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2019;15:158\u201367.","journal-title":"Alzheimer\u2019s Dement"},{"key":"731_CR88","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.neuron.2019.01.014","volume":"101","author":"M Merlini","year":"2019","unstructured":"Merlini M, Rafalski VA, Rios Coronado PE, Gill TM, Ellisman M, Muthukumar G, et al. Fibrinogen induces microglia-mediated spine elimination and cognitive impairment in an Alzheimer\u2019s disease model. Neuron. 2019;101:1099\u20131108.e1096.","journal-title":"Neuron"},{"key":"731_CR89","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","volume":"80","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Holtzman DM. Biomarker modeling of Alzheimer\u2019s disease. Neuron. 2013;80:1347\u201358.","journal-title":"Neuron"},{"key":"731_CR90","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","volume":"388","author":"P Scheltens","year":"2016","unstructured":"Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, et al. Alzheimer\u2019s disease. Lancet. 2016;388:505\u201317.","journal-title":"Lancet"},{"key":"731_CR91","doi-asserted-by":"crossref","unstructured":"Leuzy A, Chiotis K, Lemoine L, Gillberg PG, Almkvist O, Rodriguez-Vieitez E, et al. Tau PET imaging in neurodegenerative tauopathies-still a challenge. Mol Psychiatry. 2019;24:1112\u201334.","DOI":"10.1038\/s41380-018-0342-8"},{"key":"731_CR92","doi-asserted-by":"crossref","unstructured":"Kapogiannis D, Mustapic M, Shardell MD, Berkowitz ST, Diehl TC, Spangler RD, et al. Association of extracellular vesicle biomarkers with Alzheimer disease in the Baltimore Longitudinal Study of Aging. JAMA Neurol. 2019;76:1340\u201351.","DOI":"10.1001\/jamaneurol.2019.2462"},{"key":"731_CR93","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, et al. Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019;25:270\u20136.","journal-title":"Nat Med"},{"key":"731_CR94","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jalz.2018.10.003","volume":"15","author":"RER Slot","year":"2019","unstructured":"Slot RER, Sikkes SAM, Berkhof J, Brodaty H, Buckley R, Cavedo E, et al. Subjective cognitive decline and rates of incident Alzheimer\u2019s disease and non-Alzheimer\u2019s disease dementia. Alzheimer\u2019s Dement. 2019;15:465\u201376.","journal-title":"Alzheimer\u2019s Dement"},{"key":"731_CR95","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature11087","volume":"485","author":"RD Bell","year":"2012","unstructured":"Bell RD, Winkler EA, Singh I, Sagare AP, Deane R, Wu Z, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature. 2012;485:512\u20136.","journal-title":"Nature"},{"key":"731_CR96","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1001\/jamaneurol.2013.3841","volume":"70","author":"MR Halliday","year":"2013","unstructured":"Halliday MR, Pomara N, Sagare AP, Mack WJ, Frangione B, Zlokovic BV. Relationship between cyclophilin a levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein e4 carriers and blood-brain barrier breakdown. JAMA Neurol. 2013;70:1198\u2013200.","journal-title":"JAMA Neurol"},{"key":"731_CR97","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jalz.2017.07.755","volume":"14","author":"MR Azarpazhooh","year":"2018","unstructured":"Azarpazhooh MR, Avan A, Cipriano LE, Munoz DG, Sposato LA, Hachinski V. Concomitant vascular and neurodegenerative pathologies double the risk of dementia. Alzheimer\u2019s Dement. 2018;14:148\u201356.","journal-title":"Alzheimer\u2019s Dement"},{"key":"731_CR98","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","volume":"134","author":"A Kapasi","year":"2017","unstructured":"Kapasi A, DeCarli C, Schneider JA. Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol. 2017;134:171\u201386.","journal-title":"Acta Neuropathol"},{"key":"731_CR99","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ana.25399","volume":"85","author":"JS Rabin","year":"2019","unstructured":"Rabin JS, Yang HS, Schultz AP, Hanseeuw BJ, Hedden T, Viswanathan A, et al. Vascular risk and beta-amyloid are synergistically associated with cortical tau. Ann Neurol. 2019;85:272\u20139.","journal-title":"Ann Neurol"},{"key":"731_CR100","doi-asserted-by":"crossref","unstructured":"Szoeke C, Goodwill AM, Gorelik A, Dennerstein L, Caeyenberghs K, Simpson S, et al. Apolipoprotein E4 mediates the association between midlife dyslipidemia and cerebral amyloid in aging women. J Alzheimer\u2019s Dis. 2019;68:105\u201314.","DOI":"10.3233\/JAD-180815"},{"key":"731_CR101","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pneurobio.2017.03.001","volume":"153","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Song W. Islet amyloid polypeptide: another key molecule in Alzheimer\u2019s pathogenesis? Prog Neurobiol. 2017;153:100\u201320.","journal-title":"Prog Neurobiol"},{"key":"731_CR102","doi-asserted-by":"crossref","unstructured":"Robert J, Button EB, Yuen B, Gilmour M, Kang K, Bahrabadi A, et al. Clearance of beta-amyloid is facilitated by apolipoprotein E and circulating high-density lipoproteins in bioengineered human vessels. eLife. 2017;6:e29595.","DOI":"10.7554\/eLife.29595"},{"key":"731_CR103","doi-asserted-by":"crossref","first-page":"15502","DOI":"10.1073\/pnas.1206446109","volume":"109","author":"JM Castellano","year":"2012","unstructured":"Castellano JM, Deane R, Gottesdiener AJ, Verghese PB, Stewart FR, West T, et al. Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Abeta clearance in a mouse model of beta-amyloidosis. Proc Natl Acad Sci USA. 2012;109:15502\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"731_CR104","volume":"13","author":"Q Ma","year":"2018","unstructured":"Ma Q, Zhao Z, Sagare AP, Wu Y, Wang M, Owens NC, et al. Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-beta42 by LRP1-dependent apolipoprotein E isoform-specific mechanism. Mol Neurodegener. 2018;13:57.","journal-title":"Mol Neurodegener"},{"key":"731_CR105","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nature04480","volume":"438","author":"K Alitalo","year":"2005","unstructured":"Alitalo K, Tammela T, Petrova TV. Lymphangiogenesis in development and human disease. Nature. 2005;438:946.","journal-title":"Nature"},{"key":"731_CR106","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cell.2010.01.045","volume":"140","author":"T Tammela","year":"2010","unstructured":"Tammela T, Alitalo K. Lymphangiogenesis: molecular mechanisms and future promise. Cell. 2010;140:460\u201376.","journal-title":"Cell"},{"key":"731_CR107","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nature14483","volume":"522","author":"L Klotz","year":"2015","unstructured":"Klotz L, Norman S, Vieira JM, Masters M, Rohling M, Dube KN, et al. Cardiac lymphatics are heterogeneous in origin and respond to injury. Nature. 2015;522:62\u20137.","journal-title":"Nature"},{"key":"731_CR108","doi-asserted-by":"crossref","unstructured":"Pichol-Thievend C, Betterman KL, Liu X, Ma W, Skoczylas R, Lesieur E, et al. A blood capillary plexus-derived population of progenitor cells contributes to genesis of the dermal lymphatic vasculature during embryonic development. Development. 2018;145:dev160184.","DOI":"10.1242\/dev.160184"},{"key":"731_CR109","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1161\/CIRCRESAHA.116.306170","volume":"116","author":"I Martinez-Corral","year":"2015","unstructured":"Martinez-Corral I, Ulvmar MH, Stanczuk L, Tatin F, Kizhatil K, John SW, et al. Nonvenous origin of dermal lymphatic vasculature. Circ Res. 2015;116:1649\u201354.","journal-title":"Circ Res"},{"key":"731_CR110","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1016\/S0140-6736(03)15114-8","volume":"362","author":"IK Lukic","year":"2003","unstructured":"Lukic IK, Gluncic V, Ivkic G, Hubenstorf M, Marusic A. Virtual dissection: a lesson from the 18th century. Lancet. 2003;362:2110\u20133.","journal-title":"Lancet"},{"key":"731_CR111","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1159\/000142849","volume":"64","author":"M Foldi","year":"1966","unstructured":"Foldi M, Gellert A, Kozma M, Poberai M, Zoltan OT, Csanda E. New contributions to the anatomical connections of the brain and the lymphatic system. Acta Anat. 1966;64:498\u2013505.","journal-title":"Acta Anat"},{"key":"731_CR112","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.424741","volume":"203","author":"JW Prineas","year":"1979","unstructured":"Prineas JW. Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord. Science. 1979;203:1123\u20135.","journal-title":"Science"},{"key":"731_CR113","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00309843","volume":"175","author":"KH Andres","year":"1987","unstructured":"Andres KH, von During M, Muszynski K, Schmidt RF. Nerve fibres and their terminals of the dura mater encephali of the rat. Anat Embryol. 1987;175:289\u2013301.","journal-title":"Anat Embryol"},{"key":"731_CR114","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/01.iop.0000249431.04116.a8","volume":"23","author":"RE Gausas","year":"2007","unstructured":"Gausas RE, Daly T, Fogt F. D2-40 expression demonstrates lymphatic vessel characteristics in the dural portion of the optic nerve sheath. Ophthalmic Plast Reconstr Surg. 2007;23:32\u20136.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"731_CR115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2220\/biomedres.29.289","volume":"29","author":"M Furukawa","year":"2008","unstructured":"Furukawa M, Shimoda H, Kajiwara T, Kato S, Yanagisawa S. Topographic study on nerve-associated lymphatic vessels in the murine craniofacial region by immunohistochemistry and electron microscopy. Biomed Res. 2008;29:289\u201396.","journal-title":"Biomed Res"},{"key":"731_CR116","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00005072-196707000-00005","volume":"26","author":"JD Waggener","year":"1967","unstructured":"Waggener JD, Beggs J. The membranous coverings of neural tissues: an electron microscopy study. J Neuropathol Exp Neurol. 1967;26:412\u201326.","journal-title":"J Neuropathol Exp Neurol"},{"key":"731_CR117","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00439-014-1456-y","volume":"133","author":"M Alders","year":"2014","unstructured":"Alders M, Al-Gazali L, Cordeiro I, Dallapiccola B, Garavelli L, Tuysuz B, et al. Hennekam syndrome can be caused by FAT4 mutations and be allelic to Van Maldergem syndrome. Hum Genet. 2014;133:1161\u20137.","journal-title":"Hum Genet"},{"key":"731_CR118","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jaad.2014.10.033","volume":"72","author":"M Berton","year":"2015","unstructured":"Berton M, Lorette G, Baulieu F, Lagrue E, Blesson S, Cambazard F, et al. Generalized lymphedema associated with neurologic signs (GLANS) syndrome: a new entity? J Am Acad Dermatol. 2015;72:333\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"731_CR119","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523:337\u201341.","journal-title":"Nature"},{"key":"731_CR120","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1084\/jem.20170391","volume":"214","author":"S Antila","year":"2017","unstructured":"Antila S, Karaman S, Nurmi H, Airavaara M, Voutilainen MH, Mathivet T, et al. Development and plasticity of meningeal lymphatic vessels. J Exp Med. 2017;214:3645\u201367.","journal-title":"J Exp Med"},{"key":"731_CR121","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.20142290","volume":"212","author":"A Aspelund","year":"2015","unstructured":"Aspelund A, Antila S, Proulx ST, Karlsen TV, Karaman S, Detmar M, et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med. 2015;212:991\u20139.","journal-title":"J Exp Med"},{"key":"731_CR122","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pneurobio.2017.08.007","volume":"163-164","author":"BL Sun","year":"2018","unstructured":"Sun BL, Wang LH, Yang T, Sun JY, Mao LL, Yang MF, et al. Lymphatic drainage system of the brain: a novel target for intervention of neurological diseases. Prog Neurobiol. 2018;163-164:118\u201343.","journal-title":"Prog Neurobiol"},{"key":"731_CR123","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.conb.2019.11.010","volume":"62","author":"N Frederick","year":"2020","unstructured":"Frederick N, Louveau A. Meningeal lymphatics, immunity and neuroinflammation. Curr Opin Neurobiol. 2020;62:41\u20137.","journal-title":"Curr Opin Neurobiol"},{"key":"731_CR124","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/s41591-019-0417-3","volume":"25","author":"S Sandrone","year":"2019","unstructured":"Sandrone S, Moreno-Zambrano D, Kipnis J, van Gijn JA. (delayed) history of the brain lymphatic system. Nat Med. 2019;25:538\u201340.","journal-title":"Nat Med"},{"key":"731_CR125","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1172\/JCI75395","volume":"124","author":"A Aspelund","year":"2014","unstructured":"Aspelund A, Tammela T, Antila S, Nurmi H, Leppanen VM, Zarkada G, et al. The Schlemm\u2019s canal is a VEGF-C\/VEGFR-3-responsive lymphatic-like vessel. J Clin Investig. 2014;124:3975\u201386.","journal-title":"J Clin Investig"},{"key":"731_CR126","unstructured":"Aselli G. De Lacteibus sive Lacteis Venis, Quarto Vasorum Mesarai corum Genere novo invento. Milan: Mediolani; 1627."},{"key":"731_CR127","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/bdrc.20155","volume":"87","author":"MG Butler","year":"2009","unstructured":"Butler MG, Isogai S, Weinstein BM. Lymphatic development. Birth defects Res Part C. 2009;87:222\u201331.","journal-title":"Birth defects Res Part C"},{"key":"731_CR128","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCRESAHA.115.306544","volume":"118","author":"A Aspelund","year":"2016","unstructured":"Aspelund A, Robciuc MR, Karaman S, Makinen T, Alitalo K. Lymphatic system in cardiovascular medicine. Circ Res. 2016;118:515\u201330.","journal-title":"Circ Res"},{"key":"731_CR129","doi-asserted-by":"crossref","unstructured":"Absinta M, Ha SK, Nair G, Sati P, Luciano NJ, Palisoc M, et al. Human and nonhuman primate meninges harbor lymphatic vessels that can be visualized noninvasively by MRI. eLife. 2017;6:e29738.","DOI":"10.7554\/eLife.29738"},{"key":"731_CR130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.neuron.2018.09.022","volume":"100","author":"S Da Mesquita","year":"2018","unstructured":"Da Mesquita S, Fu Z, Kipnis J. The meningeal lymphatic system: a new player in neurophysiology. Neuron. 2018;100:375\u201388.","journal-title":"Neuron"},{"key":"731_CR131","doi-asserted-by":"crossref","unstructured":"Ahn JH, Cho H, Kim JH, Kim SH, Ham JS, Park I, et al. Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid. Nature. 2019;572:62\u20136.","DOI":"10.1038\/s41586-019-1419-5"},{"key":"731_CR132","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nn.4558","volume":"20","author":"NI Bower","year":"2017","unstructured":"Bower NI, Koltowska K, Pichol-Thievend C, Virshup I, Paterson S, Lagendijk AK, et al. Mural lymphatic endothelial cells regulate meningeal angiogenesis in the zebrafish. Nat Neurosci. 2017;20:774\u201383.","journal-title":"Nat Neurosci"},{"key":"731_CR133","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med. 2012;4:147ra111.","journal-title":"Sci Transl Med"},{"key":"731_CR134","volume":"8","author":"Q Ma","year":"2017","unstructured":"Ma Q, Ineichen BV, Detmar M, Proulx ST. Outflow of cerebrospinal fluid is predominantly through lymphatic vessels and is reduced in aged mice. Nat Commun. 2017;8:1434.","journal-title":"Nat Commun"},{"key":"731_CR135","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ana.24271","volume":"76","author":"BT Kress","year":"2014","unstructured":"Kress BT, Iliff JJ, Xia M, Wang M, Wei HS, Zeppenfeld D, et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol. 2014;76:845\u201361.","journal-title":"Ann Neurol"},{"key":"731_CR136","doi-asserted-by":"crossref","first-page":"248ra107","DOI":"10.1126\/scitranslmed.3008879","volume":"6","author":"JNH Stern","year":"2014","unstructured":"Stern JNH, Yaari G, Vander Heiden JA, Church G, Donahue WF, Hintzen RQ, et al. B cells populating the multiple sclerosis brain mature in the draining cervical lymph nodes. Sci Transl Med. 2014;6:248ra107\u2013248ra107.","journal-title":"Sci Transl Med"},{"key":"731_CR137","doi-asserted-by":"crossref","first-page":"248ra106","DOI":"10.1126\/scitranslmed.3008930","volume":"6","author":"A Palanichamy","year":"2014","unstructured":"Palanichamy A, Apeltsin L, Kuo TC, Sirota M, Wang S, Pitts SJ, et al. Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis. Sci Transl Med. 2014;6:248ra106\u2013248ra106.","journal-title":"Sci Transl Med"},{"key":"731_CR138","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1007\/s12035-017-0530-6","volume":"54","author":"A-FA Mentis","year":"2017","unstructured":"Mentis A-FA, Dardiotis E, Grigoriadis N, Petinaki E, Hadjigeorgiou GM. Viruses and multiple sclerosis: from mechanisms and pathways to translational research opportunities. Mol Neurobiol. 2017;54:3911\u201323.","journal-title":"Mol Neurobiol"},{"key":"731_CR139","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/ane.12775","volume":"136","author":"AFA Mentis","year":"2017","unstructured":"Mentis AFA, Dardiotis E, Grigoriadis N, Petinaki E, Hadjigeorgiou GM. Viruses and endogenous retroviruses in multiple sclerosis: from correlation to causation. Acta Neurol Scand. 2017;136:606\u201316.","journal-title":"Acta Neurol Scand"},{"key":"731_CR140","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.cell.2012.05.032","volume":"150","author":"NJ Krautler","year":"2012","unstructured":"Krautler NJ, Kana V, Kranich J, Tian Y, Perera D, Lemm D, et al. Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell. 2012;150:194\u2013206.","journal-title":"Cell"},{"key":"731_CR141","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3389\/fimmu.2018.00805","volume":"9","author":"RS Dave","year":"2018","unstructured":"Dave RS, Jain P, Byrareddy SN. Follicular dendritic cells of lymph nodes as human immunodeficiency virus\/simian immunodeficiency virus reservoirs and insights on cervical lymph node. Front Immunol. 2018;9:805\u2013805.","journal-title":"Front Immunol"},{"key":"731_CR142","doi-asserted-by":"crossref","first-page":"e1005285","DOI":"10.1371\/journal.ppat.1005285","volume":"11","author":"BA Heesters","year":"2015","unstructured":"Heesters BA, Lindqvist M, Vagefi PA, Scully EP, Schildberg FA, Altfeld M, et al. Follicular dendritic cells retain infectious HIV in cycling endosomes. PLoS Pathog. 2015;11:e1005285.","journal-title":"PLoS Pathog"},{"key":"731_CR143","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s11481-017-9775-0","volume":"13","author":"RS Dave","year":"2018","unstructured":"Dave RS, Sharma RK, Muir RR, Haddad E, Gumber S, Villinger F, et al. FDC: TFH interactions within cervical lymph nodes of SIV-infected rhesus macaques. J Neuroimmune Pharmacol. 2018;13:204\u201318.","journal-title":"J Neuroimmune Pharmacol"},{"key":"731_CR144","doi-asserted-by":"publisher","unstructured":"Xiang M, Grosso RA, Takeda A, Pan J, Bekkhus T, Brulois K, et al. A single-cell transcriptional roadmap of the mouse and human lymph node lymphatic vasculature. 2020. https:\/\/doi.org\/10.1101\/2019.12.31.892166.","DOI":"10.1101\/2019.12.31.892166"},{"key":"731_CR145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jns.2012.07.010","volume":"322","author":"SJ Baloyannis","year":"2012","unstructured":"Baloyannis SJ, Baloyannis IS. The vascular factor in Alzheimer\u2019s disease: a study in Golgi technique and electron microscopy. J Neurol Sci. 2012;322:117\u201321.","journal-title":"J Neurol Sci"},{"key":"731_CR146","first-page":"671","volume":"45","author":"T Kimura","year":"1991","unstructured":"Kimura T, Hashimura T, Miyakawa T. Observations of microvessels in the brain with Alzheimer\u2019s disease by the scanning electron microscopy. Jpn J Psychiatry Neurol. 1991;45:671\u20136.","journal-title":"Jpn J Psychiatry Neurol"},{"key":"731_CR147","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1524-6175.2003.02402.x","volume":"5","author":"D Sica","year":"2003","unstructured":"Sica D. Calcium channel blocker-related periperal edema: can it be resolved? J Clin Hypertens. 2003;5:291\u20134, 297.","journal-title":"J Clin Hypertens"},{"key":"731_CR148","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/HYPERTENSIONAHA.119.12892","volume":"74","author":"DLK de Jong","year":"2019","unstructured":"de Jong DLK, de Heus RAA, Rijpma A, Donders R, Olde Rikkert MGM, Gunther M, et al. Effects of nilvadipine on cerebral blood flow in patients with Alzheimer disease. Hypertension. 2019;74:413\u201320.","journal-title":"Hypertension"},{"key":"731_CR149","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.2353\/ajpath.2009.080963","volume":"175","author":"HY Lim","year":"2009","unstructured":"Lim HY, Rutkowski JM, Helft J, Reddy ST, Swartz MA, Randolph GJ, et al. Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration. Am J Pathol. 2009;175:1328\u201337.","journal-title":"Am J Pathol"},{"key":"731_CR150","doi-asserted-by":"crossref","unstructured":"Broce IJ, Tan CH, Fan CC, Jansen I, Savage JE, Witoelar A, et al. Dissecting the genetic relationship between cardiovascular risk factors and Alzheimer\u2019s disease. Acta Neuropathol. 2019;137:209\u201326.","DOI":"10.1007\/s00401-018-1928-6"},{"key":"731_CR151","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1172\/JCI57513","volume":"122","author":"CY Chen","year":"2012","unstructured":"Chen CY, Bertozzi C, Zou Z, Yuan L, Lee JS, Lu M, et al. Blood flow reprograms lymphatic vessels to blood vessels. J Clin Investig. 2012;122:2006\u201317.","journal-title":"J Clin Investig"},{"key":"731_CR152","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-016-0138-8","volume":"11","author":"TM Achariyar","year":"2016","unstructured":"Achariyar TM, Li B, Peng W, Verghese PB, Shi Y, McConnell E, et al. Glymphatic distribution of CSF-derived apoE into brain is isoform specific and suppressed during sleep deprivation. Mol Neurodegener. 2016;11:74.","journal-title":"Mol Neurodegener"},{"key":"731_CR153","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","volume":"26","author":"H Oakley","year":"2006","unstructured":"Oakley H, Cole SL, Logan S, Maus E, Shao P, Craft J, et al. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation. J Neurosci. 2006;26:10129\u201340.","journal-title":"J Neurosci"},{"key":"731_CR154","doi-asserted-by":"crossref","first-page":"205846011560963","DOI":"10.1177\/2058460115609635","volume":"4","author":"PK Eide","year":"2015","unstructured":"Eide PK, Ringstad G. MRI with intrathecal MRI gadolinium contrast medium administration: a possible method to assess glymphatic function in human brain. Acta Radiol Open. 2015;4:2058460115609635.","journal-title":"Acta Radiol Open"},{"key":"731_CR155","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1172\/JCI90603","volume":"127","author":"A Louveau","year":"2017","unstructured":"Louveau A, Plog BA, Antila S, Alitalo K, Nedergaard M, Kipnis J. Understanding the functions and relationships of the glymphatic system and meningeal lymphatics. J Clin Investig. 2017;127:3210\u20139.","journal-title":"J Clin Investig"},{"key":"731_CR156","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1126\/science.aax5440","volume":"366","author":"NE Fultz","year":"2019","unstructured":"Fultz NE, Bonmassar G, Setsompop K, Stickgold RA, Rosen BR, Polimeni JR, et al. Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep. Science. 2019;366:628\u201331.","journal-title":"Science"},{"key":"731_CR157","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1241224","volume":"342","author":"L Xie","year":"2013","unstructured":"Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342:373\u20137.","journal-title":"Science"},{"key":"731_CR158","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S1474-4422(18)30318-1","volume":"17","author":"MK Rasmussen","year":"2018","unstructured":"Rasmussen MK, Mestre H, Nedergaard M. The glymphatic pathway in neurological disorders. Lancet Neurol. 2018;17:1016\u201324.","journal-title":"Lancet Neurol"},{"key":"731_CR159","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainresbull.2018.10.007","volume":"143","author":"X Cao","year":"2018","unstructured":"Cao X, Xu H, Feng W, Su D, Xiao M. Deletion of aquaporin-4 aggravates brain pathology after blocking of the meningeal lymphatic drainage. Brain Res Bull. 2018;143:83\u201396.","journal-title":"Brain Res Bull"},{"key":"731_CR160","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00401-018-1812-4","volume":"135","author":"NJ Abbott","year":"2018","unstructured":"Abbott NJ, Pizzo ME, Preston JE, Janigro D, Thorne RG. The role of brain barriers in fluid movement in the CNS: is there a \u2018glymphatic\u2019 system? Acta Neuropathol. 2018;135:387\u2013407.","journal-title":"Acta Neuropathol"},{"key":"731_CR161","doi-asserted-by":"crossref","unstructured":"Smith AJ, Yao X, Dix JA, Jin BJ, Verkman AS. Test of the \u2018glymphatic\u2019 hypothesis demonstrates diffusive and aquaporin-4-independent solute transport in rodent brain parenchyma. eLife. 2017;6:e27679.","DOI":"10.7554\/eLife.27679"},{"key":"731_CR162","doi-asserted-by":"crossref","unstructured":"Mestre H, Hablitz LM, Xavier AL, Feng W, Zou W, Pu T, et al. Aquaporin-4-dependent glymphatic solute transport in the rodent brain. eLife. 2018;7:e40070.","DOI":"10.7554\/eLife.40070"},{"key":"731_CR163","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"YT Lin","year":"2018","unstructured":"Lin YT, Seo J, Gao F, Feldman HM, Wen HL, Penney J, et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron. 2018;98:1141\u20131154.e1147.","journal-title":"Neuron"},{"key":"731_CR164","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","volume":"50","author":"TR Hammond","year":"2019","unstructured":"Hammond TR, Dufort C, Dissing-Olesen L, Giera S, Young A, Wysoker A, et al. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity. 2019;50:253\u2013271.e256.","journal-title":"Immunity"},{"key":"731_CR165","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1194637","volume":"330","author":"F Ginhoux","year":"2010","unstructured":"Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330:841\u20135.","journal-title":"Science"},{"key":"731_CR166","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrm.2017.36","volume":"18","author":"M Potente","year":"2017","unstructured":"Potente M, Makinen T. Vascular heterogeneity and specialization in development and disease. Nat Rev Mol Cell Biol. 2017;18:477\u201394.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"731_CR167","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1126\/science.aaw1280","volume":"363","author":"RI Amann","year":"2019","unstructured":"Amann RI, Baichoo S, Blencowe BJ, Bork P, Borodovsky M, Brooksbank C, et al. Toward unrestricted use of public genomic data. Science. 2019;363:350\u20132.","journal-title":"Science"},{"key":"731_CR168","doi-asserted-by":"crossref","unstructured":"Penney J, Ralvenius WT, Tsai LH. Modeling Alzheimer\u2019s disease with iPSC-derived brain cells. Mol Psychiatry. 2020;25:148\u201367.","DOI":"10.1038\/s41380-019-0468-3"},{"key":"731_CR169","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.celrep.2019.01.023","volume":"26","author":"K Meyer","year":"2019","unstructured":"Meyer K, Feldman HM, Lu T, Drake D, Lim ET, Ling KH, et al. REST and neural gene network dysregulation in iPSC models of Alzheimer\u2019s disease. Cell Rep. 2019;26:1112\u20131127.e1119.","journal-title":"Cell Rep"},{"key":"731_CR170","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.tig.2013.05.010","volume":"29","author":"E Eisenberg","year":"2013","unstructured":"Eisenberg E, Levanon EY. Human housekeeping genes, revisited. Trends Genet. 2013;29:569\u201374.","journal-title":"Trends Genet"},{"key":"731_CR171","doi-asserted-by":"crossref","first-page":"15605","DOI":"10.1073\/pnas.0806883105","volume":"105","author":"NC Berchtold","year":"2008","unstructured":"Berchtold NC, Cribbs DH, Coleman PD, Rogers J, Head E, Kim R, et al. Gene expression changes in the course of normal brain aging are sexually dimorphic. Proc Natl Acad Sci USA. 2008;105:15605\u201310.","journal-title":"Proc Natl Acad Sci USA"},{"key":"731_CR172","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.nbd.2018.12.009","volume":"124","author":"M Marttinen","year":"2019","unstructured":"Marttinen M, Paananen J, Neme A, Mitra V, Takalo M, Natunen T, et al. A multiomic approach to characterize the temporal sequence in Alzheimer\u2019s disease-related pathology. Neurobiol Dis. 2019;124:454\u201368.","journal-title":"Neurobiol Dis"},{"key":"731_CR173","unstructured":"Friedman B, Hansen D. Alzheimer\u2019s gene expression by cell type\u2014SFG. 2019. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE125050."},{"key":"731_CR174","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.neurobiolaging.2011.04.013","volume":"32","author":"JE Simpson","year":"2011","unstructured":"Simpson JE, Ince PG, Shaw PJ, Heath PR, Raman R, Garwood CJ, et al. Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer\u2019s pathology and APOE genotype. Neurobiol Aging. 2011;32:1795\u2013807.","journal-title":"Neurobiol Aging"},{"key":"731_CR175","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.mcn.2007.06.009","volume":"36","author":"PT Xu","year":"2007","unstructured":"Xu PT, Li YJ, Qin XJ, Kroner C, Green-Odlum A, Xu H, et al. A SAGE study of apolipoprotein E3\/3, E3\/4 and E4\/4 allele-specific gene expression in hippocampus in Alzheimer disease. Mol Cell Neurosci. 2007;36:313\u201331.","journal-title":"Mol Cell Neurosci"},{"key":"731_CR176","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/75997","volume":"25","author":"MJ Karkkainen","year":"2000","unstructured":"Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, McTigue MA, et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet. 2000;25:153\u20139.","journal-title":"Nat Genet"},{"key":"731_CR177","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1172\/JCI58050","volume":"121","author":"E Bazigou","year":"2011","unstructured":"Bazigou E, Lyons OT, Smith A, Venn GE, Cope C, Brown NA, et al. Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. J Clin Investig. 2011;121:2984\u201392.","journal-title":"J Clin Investig"},{"key":"731_CR178","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/CIRCRESAHA.117.312576","volume":"123","author":"JA Castorena-Gonzalez","year":"2018","unstructured":"Castorena-Gonzalez JA, Zawieja SD, Li M, Srinivasan RS, Simon AM, de Wit C, et al. Mechanisms of connexin-related lymphedema. Circ Res. 2018;123:964\u201385.","journal-title":"Circ Res"},{"key":"731_CR179","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ydbio.2016.11.017","volume":"421","author":"SJ Munger","year":"2017","unstructured":"Munger SJ, Davis MJ, Simon AM. Defective lymphatic valve development and chylothorax in mice with a lymphatic-specific deletion of Connexin43. Dev Biol. 2017;421:204\u201318.","journal-title":"Dev Biol"},{"key":"731_CR180","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.devcel.2009.06.017","volume":"17","author":"E Bazigou","year":"2009","unstructured":"Bazigou E, Xie S, Chen C, Weston A, Miura N, Sorokin L, et al. Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell. 2009;17:175\u201386.","journal-title":"Dev Cell"},{"key":"731_CR181","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/lrb.2018.0007","volume":"16","author":"H Sakai","year":"2018","unstructured":"Sakai H, Fuse Y, Yamamoto T. Lymphatic vessel diameter and lymphosclerosis: two different characteristics. Lymphat Res Biol. 2018;16:317.","journal-title":"Lymphat Res Biol"},{"key":"731_CR182","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1089\/lrb.2017.0055","volume":"16","author":"M Mihara","year":"2018","unstructured":"Mihara M, Hara H, Kawakami Y, Zhou HP, Tange S, Kikuchi K, et al. Site specific evaluation of lymphatic vessel sclerosis in lower limb lymphedema patients. Lymphat Res Biol. 2018;16:360\u20137.","journal-title":"Lymphat Res Biol"},{"key":"731_CR183","doi-asserted-by":"crossref","unstructured":"Dupont G, Iwanaga J, Yilmaz E, Tubbs RS. Connections between amyloid beta and the meningeal lymphatics as a possible route for clearance and therapeutics. Lymphat Res Biol. 2020;18:2\u20136.","DOI":"10.1089\/lrb.2018.0079"},{"key":"731_CR184","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.nbd.2014.07.012","volume":"71","author":"M Pappolla","year":"2014","unstructured":"Pappolla M, Sambamurti K, Vidal R, Pacheco-Quinto J, Poeggeler B, Matsubara E. Evidence for lymphatic A\u03b2 clearance in Alzheimer\u2019s transgenic mice. Neurobiol Dis. 2014;71:215\u20139.","journal-title":"Neurobiol Dis"},{"key":"731_CR185","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13024-019-0312-x","volume":"14","author":"TK Patel","year":"2019","unstructured":"Patel TK, Habimana-Griffin L, Gao X, Xu B, Achilefu S, Alitalo K, et al. Dural lymphatics regulate clearance of extracellular tau from the CNS. Mol Neurodegener. 2019;14:11\u201311.","journal-title":"Mol Neurodegener"},{"key":"731_CR186","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/bpa.12656","volume":"29","author":"L Wang","year":"2019","unstructured":"Wang L, Zhang Y, Zhao Y, Marshall C, Wu T, Xiao M. Deep cervical lymph node ligation aggravates AD-like pathology of APP\/PS1 mice. Brain Pathol. 2019;29:176\u201392.","journal-title":"Brain Pathol"},{"key":"731_CR187","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4103\/1673-5374.230299","volume":"13","author":"Y-R Wen","year":"2018","unstructured":"Wen Y-R, Yang J-H, Wang X, Yao Z-B. Induced dural lymphangiogenesis facilities soluble amyloid-beta clearance from brain in a transgenic mouse model of Alzheimer\u2019s disease. Neural Regen Res. 2018;13:709\u201316.","journal-title":"Neural Regen Res"},{"key":"731_CR188","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/PRS.0000000000003690","volume":"140","author":"T Yamamoto","year":"2017","unstructured":"Yamamoto T, Yamamoto N, Yoshimatsu H, Narushima M, Koshima I. Factors associated with lymphosclerosis: an analysis on 962 lymphatic vessels. Plast Reconstr Surg. 2017;140:734\u201341.","journal-title":"Plast Reconstr Surg"},{"key":"731_CR189","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.mvr.2006.05.009","volume":"72","author":"JM Rutkowski","year":"2006","unstructured":"Rutkowski JM, Moya M, Johannes J, Goldman J, Swartz MA. Secondary lymphedema in the mouse tail: lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. Microvasc Res. 2006;72:161\u201371.","journal-title":"Microvasc Res"},{"key":"731_CR190","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.ajpath.2016.04.006","volume":"186","author":"E Gousopoulos","year":"2016","unstructured":"Gousopoulos E, Proulx ST, Scholl J, Uecker M, Detmar M. Prominent lymphatic vessel hyperplasia with progressive dysfunction and distinct immune cell infiltration in lymphedema. Am J Pathol. 2016;186:2193\u2013203.","journal-title":"Am J Pathol"},{"key":"731_CR191","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/s41593-018-0227-9","volume":"21","author":"A Louveau","year":"2018","unstructured":"Louveau A, Herz J, Alme MN, Salvador AF, Dong MQ, Viar KE, et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci. 2018;21:1380\u201391.","journal-title":"Nat Neurosci"},{"key":"731_CR192","volume":"10","author":"M Hsu","year":"2019","unstructured":"Hsu M, Rayasam A, Kijak JA, Choi YH, Harding JS, Marcus SA, et al. Neuroinflammation-induced lymphangiogenesis near the cribriform plate contributes to drainage of CNS-derived antigens and immune cells. Nat Commun. 2019;10:229.","journal-title":"Nat Commun"},{"key":"731_CR193","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jalz.2018.12.019","volume":"15","author":"SE Schindler","year":"2019","unstructured":"Schindler SE, Li Y, Todd KW, Herries EM, Henson RL, Gray JD, et al. Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2019;15:655\u201365.","journal-title":"Alzheimer\u2019s Dement"},{"key":"731_CR194","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jalz.2018.01.012","volume":"14","author":"CL Sutphen","year":"2018","unstructured":"Sutphen CL, McCue L, Herries EM, Xiong C, Ladenson JH, Holtzman DM, et al. Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2018;14:869\u201379.","journal-title":"Alzheimer\u2019s Dement"},{"key":"731_CR195","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neurobiolaging.2018.12.019","volume":"76","author":"R Taipa","year":"2019","unstructured":"Taipa R, das Neves SP, Sousa AL, Fernandes J, Pinto C, Correia AP, et al. Proinflammatory and anti-inflammatory cytokines in the CSF of patients with Alzheimer\u2019s disease and their correlation with cognitive decline. Neurobiol Aging. 2019;76:125\u201332.","journal-title":"Neurobiol Aging"},{"key":"731_CR196","doi-asserted-by":"publisher","unstructured":"Krance SH, Wu C-Y, Zou Y, Mao H, Toufighi S, He X, et al. The complement cascade in Alzheimer\u2019s disease: a systematic review and meta-analysis. Mol Psychiatry. 2019. https:\/\/doi.org\/10.1038\/s41380-41019-40536-41388.","DOI":"10.1038\/s41380-41019-40536-41388"},{"key":"731_CR197","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","volume":"541","author":"SA Liddelow","year":"2017","unstructured":"Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481\u20137.","journal-title":"Nature"},{"key":"731_CR198","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell. 2017;169:1276\u2013.e1217.","journal-title":"Cell"},{"key":"731_CR199","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/mp.2017.246","volume":"23","author":"KE Hopperton","year":"2018","unstructured":"Hopperton KE, Mohammad D, Trepanier MO, Giuliano V, Bazinet RP. Markers of microglia in post-mortem brain samples from patients with Alzheimer\u2019s disease: a systematic review. Mol Psychiatry. 2018;23:177\u201398.","journal-title":"Mol Psychiatry"},{"key":"731_CR200","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-08279-3","volume":"10","author":"D Felsky","year":"2019","unstructured":"Felsky D, Roostaei T, Nho K, Risacher SL, Bradshaw EM, Petyuk V, et al. Neuropathological correlates and genetic architecture of microglial activation in elderly human brain. Nat Commun. 2019;10:409.","journal-title":"Nat Commun"},{"key":"731_CR201","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1084\/jem.20190980","volume":"216","author":"Y Shi","year":"2019","unstructured":"Shi Y, Manis M, Long J, Wang K, Sullivan PM, Remolina Serrano J, et al. Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model. J Exp Med. 2019;216:2546\u201361.","journal-title":"J Exp Med"},{"key":"731_CR202","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3233\/JAD-160182","volume":"53","author":"S Salomon-Zimri","year":"2016","unstructured":"Salomon-Zimri S, Glat MJ, Barhum Y, Luz I, Boehm-Cagan A, Liraz O, et al. Reversal of ApoE4-driven brain pathology by vascular endothelial growth factor treatment. J Alzheimer\u2019s Dis. 2016;53:1443\u201358.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"731_CR203","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa1502214","volume":"373","author":"M Claussnitzer","year":"2015","unstructured":"Claussnitzer M, Dankel SN, Kim KH, Quon G, Meuleman W, Haugen C, et al. FTO obesity variant circuitry and adipocyte browning in humans. N Engl J Med. 2015;373:895\u2013907.","journal-title":"N Engl J Med"},{"key":"731_CR204","doi-asserted-by":"crossref","unstructured":"Thul PJ, Akesson L, Wiking M, Mahdessian D, Geladaki A, Ait Blal H, et al. A subcellular map of the human proteome. Science. 2017;356:eaal3321.","DOI":"10.1126\/science.aal3321"},{"key":"731_CR205","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/acn3.274","volume":"3","author":"S Janelidze","year":"2016","unstructured":"Janelidze S, Zetterberg H, Mattsson N, Palmqvist S, Vanderstichele H, Lindberg O, et al. CSF Abeta42\/Abeta40 and Abeta42\/Abeta38 ratios: better diagnostic markers of Alzheimer disease. Ann Clin Transl Neurol. 2016;3:154\u201365.","journal-title":"Ann Clin Transl Neurol"},{"key":"731_CR206","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1373\/clinchem.2009.130518","volume":"56","author":"C Mulder","year":"2010","unstructured":"Mulder C, Verwey NA, van der Flier WM, Bouwman FH, Kok A, van Elk EJ, et al. Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. Clin Chem. 2010;56:248\u201353.","journal-title":"Clin Chem"},{"key":"731_CR207","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jalz.2019.01.004","volume":"15","author":"I Bos","year":"2019","unstructured":"Bos I, Vos S, Verhey F, Scheltens P, Teunissen C, Engelborghs S, et al. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer\u2019s disease spectrum. Alzheimer\u2019s Dement. 2019;15:644\u201354.","journal-title":"Alzheimer\u2019s Dement"},{"key":"731_CR208","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.jalz.2019.03.009","volume":"15","author":"A Vergallo","year":"2019","unstructured":"Vergallo A, Megret L, Lista S, Cavedo E, Zetterberg H, Blennow K, et al. Plasma amyloid beta 40\/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2019;15:764\u201375.","journal-title":"Alzheimer\u2019s Dement"},{"key":"731_CR209","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","volume":"14","author":"MM Mielke","year":"2018","unstructured":"Mielke MM, Hagen CE, Xu J, Chai X, Vemuri P, Lowe VJ, et al. Plasma phospho-tau181 increases with Alzheimer\u2019s disease clinical severity and is associated with tau- and amyloid-positron emission tomography. Alzheimer\u2019s Dement. 2018;14:989\u201397.","journal-title":"Alzheimer\u2019s Dement"},{"key":"731_CR210","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.15252\/emmm.201606540","volume":"8","author":"N Mattsson","year":"2016","unstructured":"Mattsson N, Insel PS, Palmqvist S, Portelius E, Zetterberg H, Weiner M, et al. Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer\u2019s disease. EMBO Mol Med. 2016;8:1184\u201396.","journal-title":"EMBO Mol Med"},{"key":"731_CR211","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/mp.2016.206","volume":"22","author":"VR Varma","year":"2017","unstructured":"Varma VR, Varma S, An Y, Hohman TJ, Seddighi S, Casanova R, et al. Alpha-2 macroglobulin in Alzheimer\u2019s disease: a marker of neuronal injury through the RCAN1 pathway. Mol Psychiatry. 2017;22:13\u201323.","journal-title":"Mol Psychiatry"},{"key":"731_CR212","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.pnpbp.2017.05.019","volume":"81","author":"W Feng","year":"2018","unstructured":"Feng W, Liu HK, Kawauchi D. CRISPR-engineered genome editing for the next generation neurological disease modeling. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;81:459\u201367.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"731_CR213","volume":"9","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Ulvmar MH, Stanczuk L, Martinez-Corral I, Frye M, Alitalo K, et al. Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms. Nat Commun. 2018;9:1296.","journal-title":"Nat Commun"},{"key":"731_CR214","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1749-6632.2002.tb04878.x","volume":"979","author":"AA Gashev","year":"2002","unstructured":"Gashev AA. Physiologic aspects of lymphatic contractile function: current perspectives. Ann N Y Acad Sci. 2002;979:178\u201396.","journal-title":"Ann N Y Acad Sci"},{"key":"731_CR215","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.cell.2019.04.001","volume":"177","author":"MS Ioannou","year":"2019","unstructured":"Ioannou MS, Jackson J, Sheu SH, Chang CL, Weigel AV, Liu H, et al. Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity. Cell. 2019;177:1522\u2013.e1514.","journal-title":"Cell"},{"key":"731_CR216","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys H, Davila-Velderrain J, Peng Z, Gao F, Mohammadi S, Young JZ, et al. Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature. 2019;570:332\u20137.","journal-title":"Nature"},{"key":"731_CR217","doi-asserted-by":"crossref","unstructured":"Mastorakos P, McGavern D. The anatomy and immunology of vasculature in the central nervous system. Sci Immunol. 2019;4:eaav0492.","DOI":"10.1126\/sciimmunol.aav0492"},{"key":"731_CR218","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41593-018-0301-3","volume":"22","author":"R Cai","year":"2019","unstructured":"Cai R, Pan C, Ghasemigharagoz A, Todorov MI, F\u00f6rstera B, Zhao S, et al. Panoptic imaging of transparent mice reveals whole-body neuronal projections and skull\u2013meninges connections. Nat Neurosci. 2019;22:317\u201327.","journal-title":"Nat Neurosci"},{"key":"731_CR219","doi-asserted-by":"publisher","unstructured":"Mahoney ER, Dumitrescu L, Moore AM, Cambronero FE, De Jager PL, Koran MEI, et al. Brain expression of the vascular endothelial growth factor gene family in cognitive aging and alzheimer\u2019s disease. Mol Psychiatry. 2019. https:\/\/doi.org\/10.1038\/s41380-019-0458-5. [Online ahead of print].","DOI":"10.1038\/s41380-019-0458-5"},{"key":"731_CR220","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.23944","volume":"74","author":"T Psaltopoulou","year":"2013","unstructured":"Psaltopoulou T, Sergentanis TN, Panagiotakos DB, Sergentanis IN, Kosti R, Scarmeas N. Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis. Ann Neurol. 2013;74:580\u201391.","journal-title":"Ann Neurol"},{"key":"731_CR221","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/jnc.14036","volume":"143","author":"T Arendt","year":"2017","unstructured":"Arendt T, Stieler J, Ueberham U. Is sporadic Alzheimer\u2019s disease a developmental disorder? J Neurochem. 2017;143:396\u2013408.","journal-title":"J Neurochem"},{"key":"731_CR222","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jalz.2019.06.001","volume":"15","author":"V Hachinski","year":"2019","unstructured":"Hachinski V, Einhaupl K, Ganten D, Alladi S, Brayne C, Stephan BCM, et al. Preventing dementia by preventing stroke: the Berlin manifesto. Alzheimer\u2019s Dement. 2019;15:961\u201384.","journal-title":"Alzheimer\u2019s Dement"},{"key":"731_CR223","doi-asserted-by":"crossref","first-page":"eaax7171","DOI":"10.1126\/science.aax7171","volume":"367","author":"H Mestre","year":"2020","unstructured":"Mestre H, Du T, Sweeney AM, Liu G, Samson AJ, Peng W, et al. Cerebrospinal fluid influx drives acute ischemic tissue swelling. Science. 2020;367:eaax7171.","journal-title":"Science"},{"key":"731_CR224","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(18)30033-4","volume":"17","author":"JM Costerus","year":"2018","unstructured":"Costerus JM, Brouwer MC, van de Beek D. Technological advances and changing indications for lumbar puncture in neurological disorders. Lancet Neurol. 2018;17:268\u201378.","journal-title":"Lancet Neurol"},{"key":"731_CR225","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1172\/JCI71544","volume":"124","author":"MG Mohammad","year":"2014","unstructured":"Mohammad MG, Tsai VWW, Ruitenberg MJ, Hassanpour M, Li H, Hart PH, et al. Immune cell trafficking from the brain maintains CNS immune tolerance. J Clin Investig. 2014;124:1228\u201341.","journal-title":"J Clin Investig"},{"key":"731_CR226","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fmed.2018.00067","volume":"5","author":"AA Mentis","year":"2018","unstructured":"Mentis AA, Pantelidi K, Dardiotis E, Hadjigeorgiou GM, Petinaki E. Precision medicine and global health: the good, the bad, and the ugly. Front Med. 2018;5:67.","journal-title":"Front Med"},{"key":"731_CR227","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/978-1-4939-7868-7_12","volume":"1793","author":"PI Kontou","year":"2018","unstructured":"Kontou PI, Pavlopoulou A, Bagos PG. Methods of analysis and meta-analysis for identifying differentially expressed genes. Methods Mol Biol. 2018;1793:183\u2013210.","journal-title":"Methods Mol Biol"},{"key":"731_CR228","doi-asserted-by":"crossref","unstructured":"Bolstad BM, Collin F, Brettschneider J, Simpson K, Cope L, Irizarry R, et al. Quality assessment of Affymetrix GeneChip data. In: Bioinformatics and computational biology solutions using R and bioconductor. Springer; Berlin\/Heidelberg, Germany; 2005. p 33\u201347.","DOI":"10.1007\/0-387-29362-0_3"},{"key":"731_CR229","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57:289\u2013300.","journal-title":"J R Stat Soc"},{"key":"731_CR230","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"731_CR231","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1093\/nar\/gks042","volume":"40","author":"DJ McCarthy","year":"2012","unstructured":"McCarthy DJ, Chen Y, Smyth GK. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012;40:4288\u201397.","journal-title":"Nucleic Acids Res"},{"key":"731_CR232","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41593-018-0154-9","volume":"21","author":"S Mostafavi","year":"2018","unstructured":"Mostafavi S, Gaiteri C, Sullivan SE, White CC, Tasaki S, Xu J, et al. A molecular network of the aging human brain provides insights into the pathology and cognitive decline of Alzheimer\u2019s disease. Nat Neurosci. 2018;21:811.","journal-title":"Nat Neurosci"},{"key":"731_CR233","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41583-018-0054-8","volume":"19","author":"J Gotz","year":"2018","unstructured":"Gotz J, Bodea LG, Goedert M. Rodent models for Alzheimer disease. Nat Rev Neurosci. 2018;19:583\u201398.","journal-title":"Nat Rev Neurosci"},{"key":"731_CR234","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.tig.2018.02.007","volume":"34","author":"J Verheijen","year":"2018","unstructured":"Verheijen J, Sleegers K. Understanding Alzheimer disease at the interface between genetics and transcriptomics. Trends Genet. 2018;34:434\u201347.","journal-title":"Trends Genet"},{"key":"731_CR235","doi-asserted-by":"crossref","first-page":"e1002270","DOI":"10.1371\/journal.pmed.1002270","volume":"14","author":"HM Lanoiselee","year":"2017","unstructured":"Lanoiselee HM, Nicolas G, Wallon D, Rovelet-Lecrux A, Lacour M, Rousseau S, et al. APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases. PLoS Med. 2017;14:e1002270.","journal-title":"PLoS Med"},{"key":"731_CR236","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-018-0556-z","volume":"10","author":"LM Winchester","year":"2018","unstructured":"Winchester LM, Powell J, Lovestone S, Nevado-Holgado AJ. Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer\u2019s disease. Genome Med. 2018;10:51.","journal-title":"Genome Med"},{"key":"731_CR237","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/s41588-019-0358-2","volume":"51","author":"BW Kunkle","year":"2019","unstructured":"Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer\u2019s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing. Nat Genet. 2019;51:414\u201330.","journal-title":"Nat Genet"},{"key":"731_CR238","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.celrep.2019.07.041","volume":"28","author":"SA Ojelade","year":"2019","unstructured":"Ojelade SA, Lee TV, Giagtzoglou N, Yu L, Ugur B, Li Y, et al. cindr, the Drosophila homolog of the CD2AP Alzheimer\u2019s disease risk gene, is required for synaptic transmission and proteostasis. Cell Rep. 2019;28:1799\u2013.e1795.","journal-title":"Cell Rep"},{"key":"731_CR239","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41588-018-0311-9","volume":"51","author":"IE Jansen","year":"2019","unstructured":"Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer\u2019s disease risk. Nat Genet. 2019;51:404\u201313.","journal-title":"Nat Genet"},{"key":"731_CR240","doi-asserted-by":"crossref","first-page":"e643","DOI":"10.1212\/WNL.0000000000006000","volume":"91","author":"H Jang","year":"2018","unstructured":"Jang H, Bae JB, Dardiotis E, Scarmeas N, Sachdev PS, Lipnicki DM, et al. Differential effects of completed and incomplete pregnancies on the risk of Alzheimer disease. Neurology. 2018;91:e643\u2013e651.","journal-title":"Neurology"},{"key":"731_CR241","doi-asserted-by":"crossref","first-page":"e0182048","DOI":"10.1371\/journal.pone.0182048","volume":"12","author":"CA Anastasiou","year":"2017","unstructured":"Anastasiou CA, Yannakoulia M, Kosmidis MH, Dardiotis E, Hadjigeorgiou GM, Sakka P, et al. Mediterranean diet and cognitive health: initial results from the Hellenic Longitudinal Investigation of Ageing and Diet. PloS ONE. 2017;12:e0182048.","journal-title":"PloS ONE"},{"key":"731_CR242","doi-asserted-by":"crossref","unstructured":"Servick K. Another major drug candidate targeting the brain plaques of Alzheimer\u2019s disease has failed. What\u2019s left. Science. 2019;10. https:\/\/www.sciencemag.org\/news\/2019\/03\/another-major-drug-candidate-targeting-brain-plaques-alzheimer-s-disease-has-failed (Accessed 6 August 2019).","DOI":"10.1126\/science.aax4236"},{"key":"731_CR243","volume":"10","author":"JS Park","year":"2019","unstructured":"Park JS, Lee J, Jung ES, Kim MH, Kim IB, Son H, et al. Brain somatic mutations observed in Alzheimer\u2019s disease associated with aging and dysregulation of tau phosphorylation. Nat Commun. 2019;10:3090.","journal-title":"Nat Commun"},{"key":"731_CR244","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1007\/s12035-015-9546-y","volume":"53","author":"Z Wang","year":"2016","unstructured":"Wang Z, Lei H, Zheng M, Li Y, Cui Y, Hao F. Meta-analysis of the association between Alzheimer disease and variants in GAB2, PICALM, and SORL1. Mol Neurobiol. 2016;53:6501\u201310.","journal-title":"Mol Neurobiol"},{"key":"731_CR245","doi-asserted-by":"crossref","unstructured":"Wingo TS, Cutler DJ, Wingo AP, Le N-A, Rabinovici GD, Miller BL, et al. Association of early-onset Alzheimer disease with elevated low-density lipoprotein cholesterol levels and rare genetic coding variants of APOB. JAMA Neurol. 2019;76:809\u201317.","DOI":"10.1001\/jamaneurol.2019.0648"},{"key":"731_CR246","doi-asserted-by":"publisher","unstructured":"Bis JC, Jian X, Kunkle BW, Chen Y, Hamilton-Nelson KL, Bush WS, et al. Whole exome sequencing study identifies novel rare and common Alzheimer\u2019s-Associated variants involved in immune response and transcriptional regulation. Mol Psychiatry. 2018. https:\/\/doi.org\/10.1038\/s41380-018-0112-7.","DOI":"10.1038\/s41380-018-0112-7"},{"key":"731_CR247","doi-asserted-by":"publisher","unstructured":"Ayton S, Wang Y, Diouf I, Schneider JA, Brockman J, Morris MC, et al. Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology. Mol Psychiatry. 2019. https:\/\/doi.org\/10.1038\/s41380-019-0375-7. [Online ahead of print].","DOI":"10.1038\/s41380-019-0375-7"},{"key":"731_CR248","doi-asserted-by":"crossref","unstructured":"Goozee K, Chatterjee P, James I, Shen K, Sohrabi HR, Asih PR, et al. Elevated plasma ferritin in elderly individuals with high neocortical amyloid-\u03b2 load. Mol Psychiatry. 2018;23:1807\u201312.","DOI":"10.1038\/mp.2017.146"},{"key":"731_CR249","doi-asserted-by":"crossref","unstructured":"Zhang S, Cai F, Wu Y, Bozorgmehr T, Wang Z, Zhang S, et al. A presenilin-1 mutation causes Alzheimer disease without affecting Notch signaling. Mol Psychiatry. 2020;25:603\u201313.","DOI":"10.1038\/s41380-018-0101-x"},{"key":"731_CR250","doi-asserted-by":"crossref","unstructured":"Hartl D, May P, Gu W, Mayhaus M, Pichler S, Spaniol C, et al. A rare loss-of-function variant of ADAM17 is associated with late-onset familial Alzheimer disease. Mol Psychiatry. 2020;25:629\u201339.","DOI":"10.1038\/s41380-018-0091-8"},{"key":"731_CR251","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jalz.2014.10.013","volume":"11","author":"P Roussos","year":"2015","unstructured":"Roussos P, Katsel P, Fam P, Tan W, Purohit DP, Haroutunian V. The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer\u2019s. Dement Alzheimer\u2019s Dement. 2015;11:1163\u201370.","journal-title":"Dement Alzheimer\u2019s Dement"},{"key":"731_CR252","doi-asserted-by":"crossref","unstructured":"Deming Y, Filipello F, Cignarella F, Cantoni C, Hsu S, Mikesell R, et al. The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer\u2019s disease risk. Sci Transl Med. 2019;11:eaau2291.","DOI":"10.1126\/scitranslmed.aau2291"},{"key":"731_CR253","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1474-4422(16)00065-X","volume":"15","author":"B Maloney","year":"2016","unstructured":"Maloney B, Lahiri DK. Epigenetics of dementia: understanding the disease as a transformation rather than a state. Lancet Neurol. 2016;15:760\u201374.","journal-title":"Lancet Neurol"},{"key":"731_CR254","doi-asserted-by":"crossref","unstructured":"Wolters FJ, Zonneveld HI, Licher S, Cremers LGM, Ikram MK, Koudstaal PJ, et al. Hemoglobin and anemia in relation to dementia risk and accompanying changes on brain MRI. Neurology. 2019;93:e917\u201326.","DOI":"10.1212\/WNL.0000000000008003"},{"key":"731_CR255","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1176\/appi.ajp.2014.14040480","volume":"172","author":"ME Peters","year":"2015","unstructured":"Peters ME, Schwartz S, Han D, Rabins PV, Steinberg M, Tschanz JT, et al. Neuropsychiatric symptoms as predictors of progression to severe Alzheimer\u2019s dementia and death: the Cache County Dementia Progression Study. Am J Psychiatry. 2015;172:460\u20135.","journal-title":"Am J Psychiatry"},{"key":"731_CR256","doi-asserted-by":"crossref","unstructured":"Burhanullah MH, Tschanz JT, Peters ME, Leoutsakos JM, Matyi J, Lyketsos CG, et al. Neuropsychiatric symptoms as risk factors for cognitive decline in clinically normal older adults: the Cache County Study. Am J Geriatric Psychiatry. 2020;28:64\u201371.","DOI":"10.1016\/j.jagp.2019.03.023"},{"key":"731_CR257","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00418-015-1399-y","volume":"145","author":"K Buttler","year":"2016","unstructured":"Buttler K, Lohrberg M, Gross G, Weich HA, Wilting J. Integration of CD45-positive leukocytes into newly forming lymphatics of adult mice. Histochemistry Cell Biol. 2016;145:629\u201336.","journal-title":"Histochemistry Cell Biol"},{"key":"731_CR258","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-018-0642-x","volume":"6","author":"Y Kajiwara","year":"2018","unstructured":"Kajiwara Y, Wang E, Wang M, Sin WC, Brennand KJ, Schadt E, et al. GJA1 (connexin43) is a key regulator of Alzheimer\u2019s disease pathogenesis. Acta Neuropathol Commun. 2018;6:144.","journal-title":"Acta Neuropathol Commun"},{"key":"731_CR259","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1056\/NEJMoa1900757","volume":"380","author":"RA Stern","year":"2019","unstructured":"Stern RA, Adler CH, Chen K, Navitsky M, Luo J, Dodick DW, et al. Tau positron-emission tomography in former national football league players. N Engl J Med. 2019;380:1716\u201325.","journal-title":"N Engl J Med"},{"key":"731_CR260","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.devcel.2011.12.020","volume":"22","author":"A Sabine","year":"2012","unstructured":"Sabine A, Agalarov Y, Maby-El Hajjami H, Jaquet M, Hagerling R, Pollmann C, et al. Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation. Dev Cell. 2012;22:430\u201345.","journal-title":"Dev Cell"},{"key":"731_CR261","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1172\/JCI71603","volume":"124","author":"W Zheng","year":"2014","unstructured":"Zheng W, Aspelund A, Alitalo K. Lymphangiogenic factors, mechanisms, and applications. J Clin Investig. 2014;124:878\u201387.","journal-title":"J Clin Investig"},{"key":"731_CR262","doi-asserted-by":"crossref","first-page":"E1002","DOI":"10.1002\/humu.21127","volume":"30","author":"MA van Steensel","year":"2009","unstructured":"van Steensel MA, Damstra RJ, Heitink MV, Bladergroen RS, Veraart J, Steijlen PM, et al. Novel missense mutations in the FOXC2 gene alter transcriptional activity. Hum Mutat. 2009;30:E1002\u20139.","journal-title":"Hum Mutat"},{"key":"731_CR263","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/ng.484","volume":"41","author":"M Alders","year":"2009","unstructured":"Alders M, Hogan BM, Gjini E, Salehi F, Al-Gazali L, Hennekam EA, et al. Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat Genet. 2009;41:1272\u20134.","journal-title":"Nat Genet"},{"key":"731_CR264","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/CIRCRESAHA.113.300350","volume":"112","author":"K Gordon","year":"2013","unstructured":"Gordon K, Schulte D, Brice G, Simpson MA, Roukens MG, van Impel A, et al. Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema. Circ Res. 2013;112:956\u201360.","journal-title":"Circ Res"},{"key":"731_CR265","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ajhg.2010.04.010","volume":"86","author":"RE Ferrell","year":"2010","unstructured":"Ferrell RE, Baty CJ, Kimak MA, Karlsson JM, Lawrence EC, Franke-Snyder M, et al. GJC2 missense mutations cause human lymphedema. Am J Hum Genet. 2010;86:943\u20138.","journal-title":"Am J Hum Genet"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41380-020-0731-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-020-0731-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-020-0731-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T19:55:23Z","timestamp":1722801323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-020-0731-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,30]]},"references-count":265,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["731"],"URL":"https:\/\/doi.org\/10.1038\/s41380-020-0731-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/571729","asserted-by":"object"}]},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,30]]},"assertion":[{"value":"3 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}